Regentis Biomaterials Ltd IPOs Tomorrow, Here's What You Need To Know-February 2024-www.financetom.com

Regentis Biomaterials Ltd IPOs Tomorrow, Here's What You Need To Know

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Regentis Biomaterials Ltd IPOs Tomorrow, Here's What You Need To Know

Sep 10, 2025 8:08 AM

Regentis Biomaterials Ltd IPO will take place September, 11 on the NASDAQ exchange under the ticker RGNT.

The company is offering shares at an expected price between $10.00 and $12.00 per share with an insider lock-up period of 180 days ending on March 10, 2026.

See also: Benzinga IPO Calendar

About Regentis Biomaterials Ltd

Regentis Biomaterials Ltd. is a regenerative medicine company dedicated to developing innovative tissue repair solutions that restore the health and enhance quality of life of patients.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Previous page： Keystone oil pipeline offline due to operational issues, sources say Next page： Bristol-Myers Squibb's Opdivo Combination Therapy Receives FDA Approval for Bladder Cancer Treatment

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Keystone oil pipeline offline due to operational issues, sources say

Mar 7, 2024

WINNIPEG, Manitoba, March 7 (Reuters) - TC Energy's ( TRP ) Keystone oil pipeline is offline due to operational issues, cutting off a major conduit of Canadian oil to the United States, two industry sources said on Thursday. The 622,000 barrel-per-day pipeline has been dogged by problems, including a 2022 spill in rural Kansas. TC did not immediately respond to...

Bristol-Myers Squibb's Opdivo Combination Therapy Receives FDA Approval for Bladder Cancer Treatment

Mar 7, 2024

03:47 PM EST, 03/07/2024 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) said Thursday the US Food and Drug Administration approved the company's immunotherapy drug Opdivo, combined with chemotherapy, as a primary treatment option for adults facing urothelial carcinoma, a type of bladder cancer. The FDA's decision, based on the company's CHECKMATE-901 trial, revealed a statistically significant survival benefit of...

DraftKings to Launch Sportsbook Betting App in North Carolina

Mar 7, 2024

03:52 PM EST, 03/07/2024 (MT Newswires) -- DraftKings ( DKNG ) said Thursday it intends to launch its online sportsbook in North Carolina on Monday. DraftKings Sportsbook will expand to 27 US states with the addition of North Carolina, according to the company. The company shares were up 2.7% in recent trading. Price: 42.75, Change: +1.11, Percent Change: +2.68 ...

Astra Space to be Acquired by Entity Formed by CEO, Chief Technology Officer

Mar 7, 2024

03:54 PM EST, 03/07/2024 (MT Newswires) -- Astra Space ( ASTR ) said it has agreed to be acquired by an entity formed by Astra Chief Executive Chris Kemp and Chief Technology Officer Adam London. The entity will acquire all Astra shares it does not already own for $0.50 per share in cash, the company said. The board approved the...